India, March 11 -- Shares of Sonoma Pharmaceuticals, Inc. (SNOA) jumped over 18% on Tuesday morning after the company secured extensive U.K. regulatory clearances of key wound care and dermatology products by the Medicines & Healthcare Products Regulatory Agency (MHRA).
SNOA is currently trading at $3.3150, up $0.5250 or 18.7842%, on a huge volume of 50 million shares, above average volume of 0.6 million shares, on the Nasdaq. The stock opened its trading at $4.3199 after closing Monday at $2.7900. The stock has traded between $1.9000 and $9.4000 in the past 52-week period.
Sonoma Pharmaceuticals said the products that have received regulatory clearance include the company's hypochlorous acid-based wound irrigation solution, scar manageme...